Log in
Enquire now
‌

US Patent 11859001 IL12RB1-Binding molecules and methods of use

Patent 11859001 was granted and assigned to Synthekine on January, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors
Is a
Patent
Patent
0
Current Assignee
Synthekine
Synthekine
0
Date Filed
August 5, 2021
0
Date of Patent
January 2, 2024
0
Patent Applicant
Synthekine
Synthekine
0
Patent Application Number
18017282
0
Patent Citations
‌
US Patent 8975382 Amino acid sequences directed against HER2 and polypeptides comprising the same for the treatment of cancers and/or tumors
0
‌
US Patent 8258268 Dual variable domain immunoglobulin and uses thereof
0
‌
US Patent 8921528 Bispecific fusion antibodies with enhanced serum half-life
0
‌
US Patent 10927186 T cell recruiting polypeptides based on TCR alpha/beta reactivity
0
Patent Inventor Names
Deepti Rokkam
0
Patrick J. Lupardus
0
Robert Kastelein
0
Sandro Vivona
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11859001
0
Patent Primary Examiner
‌
Dong Jiang
0
CPC Code
‌
C07K 2317/569
0
‌
C07K 2317/565
0
‌
C07K 14/7155
0
‌
C07K 16/2866
0

Find more entities like US Patent 11859001 IL12RB1-Binding molecules and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.